Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 731,097 |
|
|||||
| News | - | ||||||
| Day High | 29.54 | Low High |
|||||
| Day Low | 28.40 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immunovant Inc | IMVT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.19 | 0.66% | 28.80 | 17:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 28.72 | 28.40 | 29.54 | 28.80 | 28.61 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,900 | 731,097 | $ 29.02 | $ 21,212,953 | - | 15.33 - 45.58 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:11:35 | formt | 1,029 | $ 28.80 | USD |
Immunovant (IMVT) Options Flow Summary
Immunovant Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.19B | 145.29M | - | 0 | -210.96M | -1.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immunovant News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMVT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.20 | 30.345 | 27.33 | 28.45 | 1,209,854 | -1.40 | -4.64% |
| 1 Month | 31.56 | 33.13 | 27.33 | 30.21 | 1,064,459 | -2.76 | -8.75% |
| 3 Months | 37.20 | 39.55 | 27.33 | 33.18 | 1,171,384 | -8.40 | -22.58% |
| 6 Months | 34.64 | 45.58 | 27.33 | 36.45 | 1,347,481 | -5.84 | -16.86% |
| 1 Year | 15.54 | 45.58 | 15.33 | 31.96 | 1,490,022 | 13.26 | 85.33% |
| 3 Years | 15.41 | 45.58 | 3.145 | 20.49 | 1,062,836 | 13.39 | 86.89% |
| 5 Years | 15.88 | 53.75 | 3.145 | 21.58 | 913,574 | 12.92 | 81.36% |
Immunovant Description
| Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). |
